Related Experiment Video
Updated: Aug 22, 2026

Identifying Caspases and their Motifs that Cleave Proteins During Influenza A Virus Infection
Published on: July 21, 2022
VIAF, a conserved inhibitor of apoptosis (IAP)-interacting factor that modulates caspase activation
John C Wilkinson1, Bettina W M Richter, Amanda S Wilkinson
1Department of Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA.
Abstract:
Inhibitor of apoptosis (IAP) proteins are involved in the suppression of apoptosis, signal transduction, cell cycle control and gene regulation. Here we describe the cloning and characterization of viral IAP-associated factor (VIAF), a highly conserved, ubiquitously expressed phosphoprotein with limited homology to members of the phosducin family that associates with baculovirus Op-IAP. VIAF bound Op-IAP both in vitro and in intact cells, with each protein displaying a predominantly cytoplasmic localization. VIAF lacks a consensus IAP binding motif, and overexpression of VIAF failed to prevent Op-IAP from protecting human cells from a variety of apoptotic stimuli, suggesting that VIAF does not function as an IAP antagonist. VIAF was unable to directly inhibit caspase activation in vitro and a reduction of VIAF protein levels by RNA interference led to a decrease in Bax-mediated caspase activation, suggesting that VIAF functions to co-regulate the apoptotic cascade. Finally, VIAF is a substrate for ubiquitination mediated by Op-IAP. Thus, VIAF is a novel IAP-interacting factor that functions in caspase activation during apoptosis.
Insights
Viral IAP-associated factor (VIAF) interacts with Inhibitor of Apoptosis (IAP) proteins and regulates caspase activation during apoptosis. This study identifies VIAF as a novel co-regulator in the apoptotic cascade.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Inhibitor of apoptosis (IAP) proteins regulate crucial cellular processes including apoptosis, signal transduction, cell cycle control, and gene regulation.
- Understanding IAP-interacting factors is key to elucidating the complex mechanisms governing cell death pathways.
Purpose of the Study:
- To clone and characterize viral IAP-associated factor (VIAF), a novel protein interacting with baculovirus Op-IAP.
- To investigate the functional role of VIAF in apoptosis and its interaction with IAP proteins.
Main Methods:
- Cloning and characterization of the VIAF gene and protein.
- In vitro and in vivo binding assays to assess protein-protein interactions between VIAF and Op-IAP.
- RNA interference (RNAi) to reduce VIAF protein levels and assess its impact on caspase activation.
- Ubiquitination assays to determine if VIAF is a substrate for Op-IAP.
Main Results:
- VIAF, a conserved phosphoprotein, associates with baculovirus Op-IAP in vitro and in cells.
- VIAF does not antagonize IAP function and does not directly inhibit caspase activation.
- Reduction of VIAF levels via RNAi decreases Bax-mediated caspase activation, indicating a co-regulatory role.
- VIAF is identified as a substrate for Op-IAP-mediated ubiquitination.
Conclusions:
- VIAF is a novel IAP-interacting factor that plays a co-regulatory role in caspase activation during apoptosis.
- The interaction between VIAF and Op-IAP, along with VIAF's ubiquitination by Op-IAP, highlights a new layer of regulation in apoptotic pathways.
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
The JAK-STAT Signaling Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.

